President Donald Trump has nominated Rear Admiral Erica G. Schwartz to lead the Centers for Disease Control and Prevention (CDC), concluding a prolonged search for a permanent director amid ongoing turmoil at the agency. If confirmed by the Senate, Schwartz will assume her role as Health and Human Services Secretary Robert F. Kennedy Jr. navigates contentious health policy changes, including revisions to childhood vaccine recommendations.
Schwartz previously served as Deputy Surgeon General during the Trump administration, significantly contributing to the U.S. response to the Covid-19 pandemic. With over 20 years of military experience, she held the position of Rear Admiral and Chief Medical Officer of the Coast Guard, establishing a solid foundation for her new role.
Dr. Jay Bhattacharya has been acting as CDC director, a title he held until last month when the federal Vacancies Act-which limits the tenure of acting officials to 210 days-expired. This provision followed the dismissal of Dr. Susan Monarez, who had been the confirmed CDC director for less than a month during Trump’s second term. Monarez testified in September that she was removed from her position after resisting Kennedy’s vaccination recommendations, which she believed lacked adequate scientific backing.
Schwartz’s stance on vaccines and other public health strategies remains uncertain, raising questions about the future direction of the CDC. On the same day of Schwartz’s nomination, Trump announced Sean Slovenski as Deputy CDC Director and Chief Operating Officer, alongside Jennifer Shuford as Deputy CDC Director and Chief Medical Officer. Shuford previously led Texas’s response to a major measles outbreak, attributing the resolution to vaccination and testing efforts.
Schwartz’s nomination comes at a challenging time for the CDC, which is experiencing significant staff turnover, declining morale, and controversial shifts in U.S. vaccination policies. Recently, a judge halted a critical vaccine panel’s initiative to revise immunization policies, which included reducing the number of recommended childhood vaccinations from 17 to 11.
Trust in federal health authorities has notably declined during Kennedy’s tenure, as indicated by a February poll from KFF, which revealed diminishing confidence across the political spectrum. This decline underscores the urgency for strong, stable leadership at the CDC, particularly as public health faces complex challenges ahead.
As Schwartz prepares to potentially take the helm, stakeholders across the health sector await clarity on her policies and direction, particularly in regards to the ongoing vaccine debates that have intensified in recent months. The confirmation process will be closely watched, as Schwartz’s leadership could shape the future of public health initiatives in the United States.
Original Source: https://www.cnbc.com/2026/04/16/trump-nominates-erica-schwartz-as-cdc-director.html
Category :
Tags:
Publish Date: 2026-04-17 04:09:00
